CN108740305B - Special calcium tablet for perinatal dairy cows and preparation method thereof - Google Patents

Special calcium tablet for perinatal dairy cows and preparation method thereof Download PDF

Info

Publication number
CN108740305B
CN108740305B CN201810444459.9A CN201810444459A CN108740305B CN 108740305 B CN108740305 B CN 108740305B CN 201810444459 A CN201810444459 A CN 201810444459A CN 108740305 B CN108740305 B CN 108740305B
Authority
CN
China
Prior art keywords
calcium
vitamin
saturated fatty
fatty acid
spirulina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201810444459.9A
Other languages
Chinese (zh)
Other versions
CN108740305A (en
Inventor
李华涛
隋君霞
田文儒
曹荣峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Agricultural University
Original Assignee
Qingdao Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Agricultural University filed Critical Qingdao Agricultural University
Priority to CN201810444459.9A priority Critical patent/CN108740305B/en
Publication of CN108740305A publication Critical patent/CN108740305A/en
Application granted granted Critical
Publication of CN108740305B publication Critical patent/CN108740305B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/10Feeding-stuffs specially adapted for particular animals for ruminants
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/10Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/158Fatty acids; Fats; Products containing oils or fats
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/163Sugars; Polysaccharides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/174Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/20Inorganic substances, e.g. oligoelements
    • A23K20/24Compounds of alkaline earth metals, e.g. magnesium
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/20Inorganic substances, e.g. oligoelements
    • A23K20/28Silicates, e.g. perlites, zeolites or bentonites
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K40/00Shaping or working-up of animal feeding-stuffs
    • A23K40/20Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The special calcium tablet for the dairy cattle provided by the invention comprises calcium ions, vitamins, sucrose, starch, saturated fatty acid, zeolite powder and spirulina, wherein the weight percentages of the components are as follows: 50-60% of calcium ions, 2-5% of vitamins, 5-10% of sucrose, 6-12% of starch, 5-10% of saturated fatty acid, 3-6% of zeolite powder and 15-20% of spirulina; the saturated fatty acid serves as a coating for the calcium tablet. The invention can prevent the blood calcium concentration of the antenatal cow eating the calcium tablet from rising too fast to affect the self calcium regulation capability of the cow, can improve the immunity of the cow, and can prevent and treat the production paralysis of the cow caused by hypocalcemia after delivery.

Description

Special calcium tablet for perinatal dairy cows and preparation method thereof
Technical Field
The invention relates to a calcium tablet special for perinatal dairy cows and a preparation method thereof.
Background
The metabolic balance of calcium in the body of a cow mainly comprises two ways of taking calcium from feed and discharging the calcium to the outside of the body. Once the balance is broken, the calcium concentration in blood plasma is too high or too low, which is easy to cause diseases such as osteoporosis, bone dysplasia, productive paralysis and the like. After the delivery of the dairy cows, the blood calcium concentration is reduced sharply due to lactation, so that not only is productive paralysis easily caused, but also major losses are caused to the dairy cow breeding industry due to secondary dairy cow ketosis, forestomach atony and other postpartum diseases.
The existing milk cow calcium supplement preparations on the market are various in types, the main components are calcium lactate, calcium carbonate, calcium gluconate, calcium citrate and the like, and the common characteristics of the components are low intestinal absorption rate, poor bioavailability and large use amount, so that the calcium supplement effect is not ideal. The dosage form is that the production process of oral liquid such as common tablets, oral liquid and the like is complicated, the cost is high, the solubility of the common tablets is not good, and the like.
The amino acid chelated calcium has good water solubility, is not influenced by microorganisms and digestive juice when passing through the cattle stomach, does not generate chemical change, is directly absorbed through an amino acid specific channel in the intestinal tract, has high absorption speed, and has the absorption rate in vivo as high as more than 82%.
Saturated fatty acid is in solid state at normal temperature, is insoluble in rumen fluid, and is digested and absorbed in small intestine, so that it can improve nutrient utilization rate of milk cow, improve body condition, and increase resistance to diseases.
Disclosure of Invention
In order to overcome the problems, the invention provides the special calcium tablet for the perinatal dairy cows, which can prevent the blood calcium concentration of the prenatal dairy cows from rising too fast to influence the self calcium regulation capability of the dairy cows after the prenatal dairy cows eat the calcium tablet, can improve the immunity of the dairy cows, and can prevent and treat the production paralysis of the dairy cows caused by hypocalemia after delivery, and the preparation method thereof.
In order to solve the problems, the invention adopts the following technical scheme: a calcium tablet special for perinatal milk cow comprises calcium ion, vitamins, sucrose and starch, and also comprises saturated fatty acid, zeolite powder and Spirulina,
the weight percentages of the components are as follows: 50-60% of calcium ions, 2-5% of vitamins, 5-10% of sucrose, 6-12% of starch, 5-10% of saturated fatty acid, 3-6% of zeolite powder and 15-20% of spirulina;
the saturated fatty acid serves as a coating for the calcium tablet.
Further, the weight percentage of each component is as follows: 55% of calcium ions, 3% of vitamins, 7% of sucrose, 9% of starch, 6% of saturated fatty acid, 4% of zeolite powder and 16% of spirulina.
Further, the calcium ions comprise 1: 9: 1, ionic organic calcium, chelating organic calcium and inorganic calcium.
Further, the vitamins comprise 1: 1: 1, vitamin a, vitamin C and vitamin E.
Preferably, the saturated fatty acid is one or more of stearic acid, palmitic acid or hydrogenated oleic acid.
Preferably, the sucrose is brown sugar.
The method for preparing the calcium tablet special for the perinatal period dairy cows comprises the following steps:
(1) crushing the amino acid chelated calcium, calcium sulfate, calcium lactate, vitamin A, vitamin C, vitamin E, zeolite powder, spirulina, sucrose and starch, and sieving the crushed materials with a 100-mesh sieve for later use;
(2) weighing the amino acid chelated calcium, calcium sulfate, calcium lactate, vitamin A, vitamin C, vitamin E, zeolite powder, spirulina, sucrose and starch according to a proportion, uniformly mixing, adding water into the powder mixture, and then sequentially granulating, drying and finishing;
(3) tabletting the prepared granules by a tabletting machine, and coating by saturated fatty acid to obtain the calcium tablet special for the dairy cow.
The invention has the following beneficial effects:
the invention is used for preventing and treating the calcium deficiency of the cows, such as osteoporosis, bone dysplasia, calcium supplement of pregnant cows and lactating cows, and can prevent and treat postpartum paralysis of the cows caused by hypocalcemia after delivery and the like by adjusting the proportion of calcium and phosphorus, activating the parathyroid function of an organism, using calcium in bones and promoting the absorption of the calcium, and improving the immunity of the cows. The invention has simple process, convenient use, high bioavailability and strong stability.
According to the physiological characteristics of the perinatal dairy cattle, the prenatal calcium demand is low, and the blood calcium needs to be rapidly increased due to the fact that a large amount of calcium is lost in lactation after delivery, the perinatal dairy cattle can be effectively prevented from hypocalcemia and postpartum paralysis, amino acid chelated calcium is chelated organic calcium, the compound calcium tablet has the advantages of being good in solubility, high in absorptivity, free of toxic and side effects and the like, most of the compound calcium tablet is absorbed in small intestines, the dairy cattle are stomach recovering animals, the retention time in the stomach is long after the compound calcium tablet is eaten, the slow release effect is achieved, and the situation that the blood calcium concentration is increased too fast after the prenatal dairy cattle eat the calcium tablet to affect the calcium regulation capacity of the dairy cattle can be prevented. The calcium lactate is ionic organic calcium, is easy to absorb and good in hydrolyzation, has a faster absorption speed in vivo than amino acid chelated calcium, can slowly raise blood calcium after being taken, meets the requirement of dairy cows on calcium in perinatal period, and plays a good role in prevention and treatment.
The saturated fatty acid can keep solid state at normal temperature, is insoluble in rumen fluid, and can be digested and absorbed in small intestine, the calcium tablet coated with saturated fatty acid has long retention time in stomach, and has slow release effect, and the saturated fatty acid can improve nutrient utilization rate of milk cow, improve body condition, and increase resistance to diseases. The saturated fatty acid can improve the nutrient utilization rate of the dairy cows, effectively reduce the concentrate feed amount, reduce the rumen acidosis risk of the dairy cows and improve the production and reproduction performance of the dairy cows.
The zeolite powder and other components have interaction relation, and the spirulina exerts the effect independently; in the formula, the zeolite powder and the spirulina are indispensable for the following reasons:
the zeolite powder selected by the invention has low price, and has the advantages of adsorbability, selective adsorbability, reversible ion exchange property, adsorption of toxic and harmful metabolites in intestinal tracts and the like, has a certain inhibiting effect on harmful flora in intestinal tracts of animals, has a special adsorption effect on certain heavy metals, and eliminates, reduces or inhibits the toxic and harmful effects of mildew, heavy metals and other toxic and harmful substances on animals, thereby reducing the morbidity of the animals, improving the feed conversion rate and improving the milk yield.
However, zeolite powder will reduce the milk fat rate, therefore, the present invention selects saturated fatty acid as lipid source, spirulina as protein source; the zeolite has an open molecular structure, has multiple cavities with uniform size, and can store Ca2 in the cavities+、Mg2+The metal cations can prolong the detention time of the calcium tablet in the digestive tract, play a role of slow release, reduce the production cost and improve the production performance and the economic benefit of animals.
The spirulina contains abundant protein (60%), fat and multiple vitamins, is easy to absorb, low in price and wide in source, has the effects of resisting fatigue, increasing milk yield, increasing milk fat rate, enhancing immunity and the like, and also can improve the palatability of calcium tablets, prevent anemia, improve the environment in rumen, promote rumen bacteria to synthesize mycoprotein and improve the digestibility of crude fiber.
Detailed Description
The calcium tablet special for the perinatal dairy cows adopts the following components in percentage by weight: 50-60% of calcium ions, 2-5% of vitamins, 5-10% of sucrose, 6-12% of starch, 5-10% of saturated fatty acid, 3-6% of zeolite powder and 15-20% of spirulina, and the calcium tablet is prepared by mixing the calcium ions, the vitamins, the zeolite powder, the spirulina, the sucrose and the starch to prepare a granular calcium tablet, and finally coating the surface of the granular calcium tablet with saturated fatty acid. The specific embodiment is as follows:
example 1
The calcium ions are amino acid chelated calcium, calcium sulfate and calcium lactate.
The vitamins are selected from vitamin A, vitamin C and vitamin E.
The saturated fatty acid is selected from hydrogenated oleic acid and stearic acid.
The sucrose is brown sugar.
According to the weight percentage: 55% of calcium ions (45% of amino acid chelated calcium, 5% of calcium sulfate, 5% of calcium lactate), 6% of saturated fatty acid, 3% of vitamin (vitamin A1%, vitamin C1%, vitamin E1%), 4% of zeolite powder, 16% of spirulina, 7% of brown sugar and 9% of starch, 90 g of amino acid chelated calcium, 10 g of calcium sulfate, 10 g of calcium lactate, 12 g of saturated fatty acid, 2 g of vitamin A, 2 g of vitamin C, 2 g of vitamin E, 8 g of zeolite powder, 32 g of spirulina, 14 g of brown sugar and 18 g of starch.
The preparation method comprises the following specific steps:
(1) the amino acid chelated calcium, calcium sulfate, calcium lactate, vitamin A, vitamin C, vitamin E, zeolite powder, spirulina, brown sugar and starch are crushed and all pass through a 100-mesh sieve for later use.
(2) The preparation particles are prepared by weighing the components of the amino acid chelated calcium, the calcium sulfate, the calcium lactate, the vitamin A, the vitamin C, the vitamin E, the zeolite powder, the spirulina, the brown sugar and the starch according to the proportion, uniformly mixing by a weight increasing method to form a uniform powder mixture, then using water as a bonding agent, adding the uniform powder mixture and the powder mixture according to the proportion, preparing a soft material, granulating, drying and finishing.
(3) Tabletting the prepared granules by a tabletting machine, and coating saturated fatty acid to obtain the calcium tablet special for the dairy cow.
Example 2
The calcium ions are amino acid chelated calcium, calcium sulfate and calcium lactate.
The vitamins are selected from vitamin A, vitamin C and vitamin E.
The saturated fatty acid is selected from palmitic acid and linolenic acid.
The sucrose is brown sugar.
According to the weight percentage: calcium ion 51.7% (amino acid chelated calcium 42.3%, calcium sulfate 4.7%, calcium lactate 4.7%), saturated fatty acid 8% (palmitic acid 4% and linolenic acid 4%), vitamin 3.3% (vitamin a 1.1%, vitamin C1.1%, vitamin E1.1%), zeolite powder 3%, spirulina 17%, brown sugar 5% and starch 12%, weighing amino acid chelated calcium 84.6 g, calcium sulfate 9.4 g, calcium lactate 9.4 g, palmitic acid 8 g, linolenic acid 8 g, vitamin a 2.2 g, vitamin C2.2 g, vitamin E2.2 g, zeolite powder 6 g, spirulina 34 g, brown sugar 10 g and starch 24 g.
The preparation method comprises the following specific steps:
(1) the amino acid chelated calcium, calcium sulfate, calcium lactate, vitamin A, vitamin C, vitamin E, zeolite powder, spirulina, brown sugar and starch are crushed and all pass through a 100-mesh sieve for later use.
(2) Weighing the amino acid chelated calcium, the calcium sulfate, the calcium lactate, the vitamin A, the vitamin C, the vitamin E, the zeolite powder, the spirulina, the brown sugar and the starch according to the proportion, uniformly mixing by a weight increasing method to form a uniform powder mixture, then using water as a bonding agent, mixing the uniform powder mixture with the powder mixture according to the ratio of water to material 1: adding the raw materials in a ratio of 20, preparing soft materials, granulating, drying and finishing.
(3) Tabletting the prepared granules by a tabletting machine, and coating saturated fatty acid to obtain the calcium tablet special for the dairy cow.
The administration method of the invention is that before the perinatal period of the dairy cattle, the oral administration device is adopted for administration, 1 tablet per day and 2 days in succession, 2 tablets each time after delivery and 2 days in succession, the dairy cattle are used for health care in the peak period of the milk production, 2 tablets each time and 2 tablets each time at intervals of 1 day and 2 times in succession. The weight of each tablet was 50 grams.
The instant tablet is used for observing the effect of preventing and treating the paralytic milk cow production. Clinical diagnostic standard sick cattle try to stand, but the hind limbs can not be completely straightened, only two partially-bent hind limbs can climb along the ground, and the two hind limbs are shifted backwards, so that the spine is bent in an S shape or a C shape. Laboratory diagnostics have used an atomic absorptiometry to determine blood calcium concentrations in suspected cases.
1. Prevention test
Experimental animals in Dairy cow breeding district of Qingdao, Shandong province, Laisi, 100 antenatal cows were tested, wherein 50 cows served as test group and 2 days of calcium tablet were used before parturition, 1 tablet per day.
2. Test for treatment
Experimental animals in Dairy cow breeding district of Qingdao city, Shandong province, 24 cows with paralysis are tested and divided into a control group and a test group, the test group adopts the calcium tablet of the invention for treatment, and the control group adopts calcium gluconate preparation calcium gluconate which is dissolved in water and then drunk.
In addition, 12 cows with productive paralysis are divided into a control group and a test group, the cows in the test group are treated by one calcium tablet, and the cows in the control group are dissolved in water and then drunk. The blood calcium concentration is measured before and after administration.
3. Results
(1) The prevention effect is as follows:
the control group of 3 cattle has productive paralysis, and the blood calcium concentration is respectively determined to be 6.3 mg/ml, 7.1 mg/ml and 6.9 mg/ml which are all less than the normal blood calcium concentration (8.6 mg/ml-11.1 mg/ml) of the normal level cow;
no abnormal symptoms are found in the test group cattle, blood samples of 8 cattle are sampled and detected, and the blood calcium level is in a normal range and is respectively 8.8mg/ml, 8.3mg/ml, 8.9 mg/ml, 9.6 mg/ml, 10.3 mg/ml, 10.7 mg/ml, 10.6 mg/ml and 10.2 mg/ml.
(2) The treatment effect is as follows: the cure rate of the control group is 67%, and the absorption rates of calcium are 31.9%, 32.7%, 31.5%, 35.4%, 39.8% and 33.6% respectively.
The cure rate of the test group is 92%, and the absorption rates of calcium are 91.6%, 94.3%, 92.5%, 93.6%, 90.7% and 93.1% respectively.

Claims (6)

1. A calcium tablet special for perinatal dairy cows comprises calcium ions, vitamins, sucrose and starch, and is characterized by also comprising saturated fatty acid, zeolite powder and spirulina,
the weight percentages of the components are as follows: 50-60% of calcium ions, 2-5% of vitamins, 5-10% of sucrose, 6-12% of starch, 5-10% of saturated fatty acid, 3-6% of zeolite powder and 15-20% of spirulina;
the calcium ions comprise the following components in percentage by weight of 1: 9: 1, ionic organic calcium, chelating organic calcium and inorganic calcium; wherein the ionic organic calcium is calcium lactate, the chelating organic calcium is amino acid chelated calcium, and the inorganic calcium is calcium sulfate;
the saturated fatty acid serves as a coating for the calcium tablet.
2. The calcium tablet special for perinatal cows according to claim 1, which is characterized in that: the weight percentage of each component is as follows: 55% of calcium ions, 3% of vitamins, 7% of sucrose, 9% of starch, 6% of saturated fatty acid, 4% of zeolite powder and 16% of spirulina.
3. The calcium tablet special for perinatal cows according to claim 1, which is characterized in that: the vitamins comprise 1: 1: 1, vitamin a, vitamin C and vitamin E.
4. The calcium tablet special for perinatal cows according to claim 1, which is characterized in that: the saturated fatty acid is one or more of stearic acid, palmitic acid or hydrogenated oleic acid.
5. The calcium tablet special for perinatal cows according to claim 1, which is characterized in that: the sucrose is brown sugar.
6. A method for preparing the calcium tablet special for the perinatal cow as claimed in any one of claims 1 to 5, which comprises the following steps:
(1) crushing the amino acid chelated calcium, calcium sulfate, calcium lactate, vitamin A, vitamin C, vitamin E, zeolite powder, spirulina, sucrose and starch, and sieving the crushed materials with a 100-mesh sieve for later use;
(2) weighing the amino acid chelated calcium, calcium sulfate, calcium lactate, vitamin A, vitamin C, vitamin E, zeolite powder, spirulina, sucrose and starch according to a proportion, uniformly mixing, adding water into the powder mixture, and then sequentially granulating, drying and finishing;
(3) tabletting the prepared granules by a tabletting machine, and coating by saturated fatty acid to obtain the calcium tablet special for the dairy cow.
CN201810444459.9A 2018-05-10 2018-05-10 Special calcium tablet for perinatal dairy cows and preparation method thereof Active CN108740305B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810444459.9A CN108740305B (en) 2018-05-10 2018-05-10 Special calcium tablet for perinatal dairy cows and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810444459.9A CN108740305B (en) 2018-05-10 2018-05-10 Special calcium tablet for perinatal dairy cows and preparation method thereof

Publications (2)

Publication Number Publication Date
CN108740305A CN108740305A (en) 2018-11-06
CN108740305B true CN108740305B (en) 2021-09-17

Family

ID=64009665

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810444459.9A Active CN108740305B (en) 2018-05-10 2018-05-10 Special calcium tablet for perinatal dairy cows and preparation method thereof

Country Status (1)

Country Link
CN (1) CN108740305B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111903853A (en) * 2020-08-11 2020-11-10 黑龙江八一农垦大学 Health-care granules for relieving energy metabolism disorder of dairy cows in perinatal period and preparation method thereof
CN113693166A (en) * 2021-08-19 2021-11-26 浙江万方生物科技有限公司 Sectional type slow-release mineral element rod special for dairy cows and preparation method thereof
CN117461740A (en) * 2023-11-06 2024-01-30 中国农业大学 Mineral element metabolism regulator for preventing postpartum hypocalcemia of dairy cows and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102246909A (en) * 2010-06-21 2011-11-23 北京科兴大地饲料有限公司 Special healthcare feed for perinatal milk cows and preparing method thereof
CN102326680A (en) * 2011-07-01 2012-01-25 上海光明荷斯坦牧业有限公司 Dairy cow postpartum nutrition enhancer premix and preparation method and application thereof
CN106913856A (en) * 2017-04-07 2017-07-04 南通市第人民医院 A kind of animal specific calcium tablet and preparation method thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1189541A (en) * 1997-09-19 1999-04-06 Yakult Honsha Co Ltd Basic mineral-containing composition for oral intake
DE19807996A1 (en) * 1998-02-26 1999-09-02 Bayer Ag Piece of calcium formate
CN101947234A (en) * 2010-09-02 2011-01-19 南京威尔曼药物研究所 Preparation method for preparation containing glucosamine and application thereof
CN102318835B (en) * 2011-08-31 2013-01-09 石家庄中硕药业集团有限公司 Composition for reducing bone loss and preparation method thereof
CN105076709A (en) * 2015-09-23 2015-11-25 陈守亮 Feed for cows in lactation period and preparation method thereof
CN106490386A (en) * 2016-10-28 2017-03-15 六安市裕安区固镇军明白鹅养殖专业合作社 A kind of diet feed of the big white goose laying rate of raising Wan Xi and preparation method thereof
CN107183396A (en) * 2017-06-13 2017-09-22 徐州德诚饲料有限责任公司 A kind of milk cow cub mixed feed and preparation method thereof
CN107375221B (en) * 2017-07-12 2020-06-09 广州富诺健康科技股份有限公司 Calcium tablet containing vitamin K2 and preparation method thereof
CN107865213A (en) * 2017-09-23 2018-04-03 张超杰 A kind of method for preparing ox feed

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102246909A (en) * 2010-06-21 2011-11-23 北京科兴大地饲料有限公司 Special healthcare feed for perinatal milk cows and preparing method thereof
CN102326680A (en) * 2011-07-01 2012-01-25 上海光明荷斯坦牧业有限公司 Dairy cow postpartum nutrition enhancer premix and preparation method and application thereof
CN106913856A (en) * 2017-04-07 2017-07-04 南通市第人民医院 A kind of animal specific calcium tablet and preparation method thereof

Also Published As

Publication number Publication date
CN108740305A (en) 2018-11-06

Similar Documents

Publication Publication Date Title
CN108740305B (en) Special calcium tablet for perinatal dairy cows and preparation method thereof
ES2943679T3 (en) Reproductive capacity enhancement agent for a ruminant
AU2011336145A1 (en) Galenic composition suitable for administration to a non-human animal, uses thereof, and associated methods
US7235256B2 (en) Method of preventing parturient hypocalcemia in animals and compositions used therein
CN106578529A (en) Piglet production performance, intestinal health and antioxidant property improving composition and preparation method thereof
MX2009002503A (en) Food supplementation composition containing one or more vitamin d3 compounds and one or more magnesium salts.
Hosnedlová et al. Current view of the significance of zinc for ruminants: A review
RU2357424C2 (en) Pig fodder additive and method of pig feeding
JP5346433B2 (en) Livestock feed
EP2440213B1 (en) Use of 1,25-dihydroxyvitamine D3 glycoside in lactating animals
JP4428553B2 (en) Prophylactic and / or therapeutic agent for domestic animals
DK1776956T3 (en) An agent for the prevention and / or treatment of calcium deficiency
Wilson A novel nutritional strategy to prevent milk fever and stimulate milk production in dairy cows
US9763464B2 (en) Potassium containing preparation, process for the production thereof and use thereof
RU2530815C2 (en) Feed additive for animals and birds
RU2648458C1 (en) Method of prevention of generic and postnatal pathology in pregnant nonmilking cows
Kurćubić et al. Effect of dietary supplements of sodium bicarbonate on tissue calcium (Ca) and magnesium (Mg) levels in beef cattle.
RU2554767C2 (en) Medication for stimulation of metabolic processes and growth activity of calves
RU2555005C2 (en) Energometabolic composition for stimulation of exchange processes, prevention of hypomicroelementosis and diarrhea in piglets
RU2752956C1 (en) Method for increasing nonspecific resistance of body of calves
CN100364969C (en) Water soluble vitamins D2 preparation method
RU2723179C1 (en) Method for improving economic and useful qualities of ewes and lambs
JP5248438B2 (en) Ruminant milk production improver
US20210260032A1 (en) Composition
RU2424728C1 (en) Method for treatment and prevention of rickets with piglets

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant